Royalty Pharma plc (RPRX) Form 10-Q Quarterly Reports
Royalty Pharma plc (RPRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RPRX
CIK: 1802768
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerKevin Casey
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-05 | FORM 4 | 0001838139-26-000028 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001964306-26-000465 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-30 | FORM 4 | 0001683607-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | FORM 4 | 0001838139-26-000026 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001964306-26-000456 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | FORM 4 | 0001814238-26-000017 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001628280-26-063061 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-18 | FORM 4 | 0001814238-26-000015 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001628280-26-057721 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-17 | — | SCHEDULE 13D/A Filing | 0001193125-26-354412 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | FORM 4 | 0001814876-26-000027 | View SEC Doc Filr Page |
| 13F-NT | 2026-08-14 | 2026-06-30 | 13F-NT Filing | 0001802768-26-000018 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001958244-26-000508 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001968582-26-000828 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001968582-26-000827 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001507678-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001814876-26-000025 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001814238-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001838139-26-000024 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001802768-26-000015 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001802768-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001838139-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001814238-26-000011 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001964306-26-000306 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001628280-26-046352 | View SEC Doc Filr Page |